anti-beta-1 adrenergic receptor agonistic mAbs (Heptares)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameanti-beta-1 adrenergic receptor agonistic mAbs (Heptares)
Drug Alias Namebeta 1 adrenergic receptor modulators (Heptares Therapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionBeta-1 adrenergic receptor modulators
TargetsBeta-1 adrenergic receptor
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma UK Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNxera Pharma UK Ltd
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A